Xilio Therapeutics, Inc. (XLO)

Xilio Therapeutics Statistics

Total Valuation

XLO has a market cap or net worth of $37.20 million. The enterprise value is -$10.39 million.

Market Cap	37.20M
Enterprise Value	-10.39M

Important Dates

The last earnings date was Tuesday, March 11, 2025, before market open.

Earnings Date	Mar 11, 2025
Ex-Dividend Date	n/a

Share Statistics

XLO has 51.77 million shares outstanding. The number of shares has increased by 94.62% in one year.

Current Share Class	51.77M
Shares Outstanding	51.77M
Shares Change (YoY)	+94.62%
Shares Change (QoQ)	+1.91%
Owned by Insiders (%)	14.06%
Owned by Institutions (%)	16.39%
Float	22.00M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	6.29
Forward PS	1.57
PB Ratio	1.94
P/TBV Ratio	2.09
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.21, with a Debt / Equity ratio of 0.46.

Current Ratio	2.21
Quick Ratio	2.10
Debt / Equity	0.46
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-596.45

Financial Efficiency

Return on equity (ROE) is -214.02% and return on invested capital (ROIC) is -99.25%.

Return on Equity (ROE)	-214.02%
Return on Assets (ROA)	-56.48%
Return on Invested Capital (ROIC)	-99.25%
Return on Capital Employed (ROCE)	-136.13%
Revenue Per Employee	$99,125
Profits Per Employee	-$910,016
Employee Count	64
Asset Turnover	0.10
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +16.75% in the last 52 weeks. The beta is -0.34, so XLO's price volatility has been lower than the market average.

Beta (5Y)	-0.34
52-Week Price Change	+16.75%
50-Day Moving Average	0.87
200-Day Moving Average	0.92
Relative Strength Index (RSI)	41.08
Average Volume (20 Days)	463,598

Short Selling Information

The latest short interest is 575,448, so 1.11% of the outstanding shares have been sold short.

Short Interest	575,448
Short Previous Month	694,611
Short % of Shares Out	1.11%
Short % of Float	2.62%
Short Ratio (days to cover)	0.30

Income Statement

In the last 12 months, XLO had revenue of $6.34 million and -$58.24 million in losses. Loss per share was -$1.09.

Revenue	6.34M
Gross Profit	6.34M
Operating Income	-59.65M
Pretax Income	-65.53M
Net Income	-58.24M
EBITDA	-58.00M
EBIT	-59.65M
Loss Per Share	-$1.09

Balance Sheet

The company has $55.29 million in cash and $8.14 million in debt, giving a net cash position of $47.15 million or $0.91 per share.

Cash & Cash Equivalents	55.29M
Total Debt	8.14M
Net Cash	47.15M
Net Cash Per Share	$0.91
Equity (Book Value)	17.60M
Book Value Per Share	0.38
Working Capital	32.97M

Cash Flow

In the last 12 months, operating cash flow was -$18.38 million and capital expenditures -$36,000, giving a free cash flow of -$18.41 million.

Operating Cash Flow	-18.38M
Capital Expenditures	-36,000
Free Cash Flow	-18.41M
FCF Per Share	-$0.36

Margins

Gross Margin	100.00%
Operating Margin	-940.18%
Pretax Margin	-918.05%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

XLO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-94.62%
Shareholder Yield	-94.62%
Earnings Yield	-158.44%
FCF Yield	-50.09%

Analyst Forecast

The average price target for XLO is $4.00, which is 456.64% higher than the current price. The consensus rating is "Buy".

Price Target	$4.00
Price Target Difference	456.64%
Analyst Consensus	Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	60.25%
EPS Growth Forecast (5Y)	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

XLO has an Altman Z-Score of -9.29 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-9.29
Piotroski F-Score	1